Sze Ting Lee

4.0k total citations
69 papers, 1.2k citations indexed

About

Sze Ting Lee is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sze Ting Lee has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Radiology, Nuclear Medicine and Imaging, 32 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in Sze Ting Lee's work include Medical Imaging Techniques and Applications (16 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Prostate Cancer Treatment and Research (9 papers). Sze Ting Lee is often cited by papers focused on Medical Imaging Techniques and Applications (16 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Prostate Cancer Treatment and Research (9 papers). Sze Ting Lee collaborates with scholars based in Australia, United States and Belgium. Sze Ting Lee's co-authors include Andrew M. Scott, Hui Gan, Narjess Ayati, Sagun Parakh, Seyed Rasoul Zakavi, Ian D. Davis, Salvatore U. Berlangieri, Sylvia Gong, Nathan Lawrentschuk and Joe H. Chang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Sze Ting Lee

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sze Ting Lee Australia 20 633 428 335 235 128 69 1.2k
Helmut Dittmann Germany 20 994 1.6× 585 1.4× 371 1.1× 323 1.4× 143 1.1× 84 1.7k
D. Cobben Netherlands 15 779 1.2× 584 1.4× 253 0.8× 235 1.0× 97 0.8× 41 1.3k
Don Wilson Canada 17 413 0.7× 359 0.8× 279 0.8× 169 0.7× 95 0.7× 59 997
Andrei Todica Germany 21 840 1.3× 460 1.1× 384 1.1× 109 0.5× 166 1.3× 105 1.5k
Jawana M. Lawhorn‐Crews United States 8 859 1.4× 349 0.8× 283 0.8× 312 1.3× 152 1.2× 17 1.2k
Dominick Lamonica United States 17 695 1.1× 402 0.9× 513 1.5× 274 1.2× 106 0.8× 36 1.5k
Alexander Matthies Germany 14 616 1.0× 407 1.0× 278 0.8× 82 0.3× 172 1.3× 27 1.2k
Luca Triggiani Italy 19 275 0.4× 715 1.7× 324 1.0× 176 0.7× 206 1.6× 85 1.2k
Florian Würschmidt Germany 19 305 0.5× 500 1.2× 330 1.0× 316 1.3× 104 0.8× 49 1.0k
K. Chao United States 14 238 0.4× 304 0.7× 273 0.8× 182 0.8× 204 1.6× 34 873

Countries citing papers authored by Sze Ting Lee

Since Specialization
Citations

This map shows the geographic impact of Sze Ting Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sze Ting Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sze Ting Lee more than expected).

Fields of papers citing papers by Sze Ting Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sze Ting Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sze Ting Lee. The network helps show where Sze Ting Lee may publish in the future.

Co-authorship network of co-authors of Sze Ting Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Sze Ting Lee. A scholar is included among the top collaborators of Sze Ting Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sze Ting Lee. Sze Ting Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barraclough, Allison, Sze Ting Lee, Melinda Burgess, et al.. (2025). Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study. Blood Advances. 9(6). 1432–1441.
2.
Ninatti, Gaia, Sze Ting Lee, & Andrew M. Scott. (2025). Radioligand Therapy in Cancer Management: A Global Perspective. Cancers. 17(21). 3412–3412.
3.
Scott, Andrew M., Brian M. Zeglis, Suzanne E. Lapi, et al.. (2024). Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics. The Lancet Oncology. 25(6). e250–e259. 20 indexed citations
4.
Berlangieri, Salvatore U., et al.. (2024). Flourine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging of Peritoneal Carcinomatosis in Lung Cancer: A Case Study. World Journal of Nuclear Medicine. 23(3). 202–206. 1 indexed citations
5.
Lee, Sze Ting, Nigel J. Waters, Garry Hamilton, et al.. (2024). PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated patients with lymphoma. Blood Advances. 9(3). 499–506.
6.
Chong, Geoffrey, Jodie Palmer, Allison Barraclough, et al.. (2024). First-line treatment of follicular lymphoma (FL) with golcadamide, rituximab +/- nivolumab: An umbrella randomised phase 2 investigator-led study.. Journal of Clinical Oncology. 42(16_suppl). TPS7092–TPS7092. 2 indexed citations
7.
8.
Ayati, Narjess, et al.. (2022). The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review. European Journal of Nuclear Medicine and Molecular Imaging. 49(13). 4661–4676. 14 indexed citations
9.
10.
Lee, Sze Ting, Louise Emmett, David A. Pattison, et al.. (2022). The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian Perspective. Journal of Nuclear Medicine. 63(6). 819–822. 12 indexed citations
11.
Hapgood, Greg, Maya Latimer, Sze Ting Lee, et al.. (2021). Diagnosis, management and follow up of peripheral T‐cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal. 52(10). 1806–1817.
12.
Gan, Hui, Matthew Burge, Benjamin Solomon, et al.. (2021). A Phase 1 and Biodistribution Study of ABT-806i, an 111In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806. Journal of Nuclear Medicine. 62(6). 787–794. 15 indexed citations
13.
Scott, Andrew M., et al.. (2021). Impact of 18F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative 131I whole body scan and elevated serum thyroglobulin.. 2 indexed citations
14.
Wight, Joel, Nada Hamad, Belinda A. Campbell, et al.. (2021). Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal. 52(9). 1609–1623. 3 indexed citations
15.
Ayati, Narjess, Sze Ting Lee, Seyed Rasoul Zakavi, et al.. (2020). Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non–Small Cell Lung Cancer: Comparison of Assessment Methods. Journal of Nuclear Medicine. 62(7). 926–933. 18 indexed citations
16.
Ayati, Narjess, et al.. (2020). The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. 48(2). 428–448. 64 indexed citations
17.
Leimgruber, Antoine, Kevin Hickson, Sze Ting Lee, et al.. (2020). Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse. European Journal of Nuclear Medicine and Molecular Imaging. 47(6). 1476–1485. 19 indexed citations
18.
Herbertson, Rebecca, Niall C. Tebbutt, Fook-Thean Lee, et al.. (2014). Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of 131I-huA33 with Concurrent Capecitabine. Journal of Nuclear Medicine. 55(4). 534–539. 24 indexed citations
19.
Chang, Joe H., Morikatsu Wada, Nigel Anderson, et al.. (2013). Hypoxia-targeted radiotherapy dose painting for head and neck cancer using18F-FMISO PET: A biological modeling study. Acta Oncologica. 52(8). 1723–1729. 69 indexed citations
20.
Muralidharan, Vijayaragavan, et al.. (2012). Prognostic Ability of 18F-FDG PET/CT in the Assessment of Colorectal Liver Metastases. Journal of Nuclear Medicine. 53(9). 1345–1351. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helmut Dittmann Breakdown of academic impact, for papers by D. Cobben Breakdown of academic impact, for papers by Don Wilson Breakdown of academic impact, for papers by Andrei Todica Breakdown of academic impact, for papers by Jawana M. Lawhorn‐Crews Breakdown of academic impact, for papers by Dominick Lamonica Breakdown of academic impact, for papers by Alexander Matthies Breakdown of academic impact, for papers by Luca Triggiani Breakdown of academic impact, for papers by Florian Würschmidt Breakdown of academic impact, for papers by K. Chao
Rankless by CCL
2026